Needless platelet activity in the lungs may be one of the primary reasons clinicians are seeing inflammation and blood clotting in critically ill COVID-19 patients.

Researchers aimed to use a proven strategy to improve patient care, but their intervention did not make a substantial impact. 

The new analysis, published in JACC: Heart Failure, focused on patient data from the renowned COAPT trial. 

Researchers stressed that clinicians have an opportunity to improve their machine learning models by providing data on specific social and environmental factors. 

Cleveland Clinic retained its spot as the top hospital in the country for cardiology and heart surgery. Did your facility make the list?

Additional findings from this analysis are scheduled to be presented at Heart Rhythm 2021.

Declining elective PCI rates, a shift toward the outpatient setting and changes in the initial management of stable ischemic heart disease all appear to be responsible for the drop.

Physicians and patients may want to consider selecting ARBs instead of ACE inhibitors as an initial treatment for hypertension, based on a new analysis in Hypertension.

The authors tracked data from stroke patients, and healthy controls, between the ages of 15 and 49 years old. 

New two-year findings, presented at TVT 2021, suggest that the Watchman FLX device is a safe alternative to long-term oral anticoagulation therapy.